Skip to content

Vera Therapeutics

US · VERA #2739 by market cap Listed 2021
25.45 -1.30 -4.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Vera Therapeutics

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Founded
2016
CEO
Dr. Marshall Fordyce, M.D.
Employees
249
Headquarters
Brisbane, California, United States of America
Fiscal year end
12-31
Website
veratx.com

Company profile

Exchange
US
Symbol
VERA
Market-cap rank
#2739
Listing date
2021-05-14
Market cap
1.84B
Float cap
1.25B
Shares out
72.30M
Float shares
49.29M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Vera Therapeutics discussion 0 comments

Add a comment